vs
MACOM Technology Solutions Holdings, Inc.（MTSI）与VERACYTE, INC.（VCYT）财务数据对比。点击上方公司名可切换其他公司
MACOM Technology Solutions Holdings, Inc.的季度营收约是VERACYTE, INC.的2.0倍（$271.6M vs $139.1M），VERACYTE, INC.净利率更高（20.6% vs 18.0%，领先2.7%），MACOM Technology Solutions Holdings, Inc.同比增速更快（24.5% vs 21.5%），过去两年MACOM Technology Solutions Holdings, Inc.的营收复合增速更高（22.4% vs 10.2%）
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
Veracyte是一家领先的分子诊断企业，专注开发专有的基因组检测方案，可实现癌症及其他复杂疾病的早期精准检测，产品服务于医疗机构以优化临床决策，核心市场位于美国，正稳步拓展全球业务布局。
MTSI vs VCYT — 直观对比
营收规模更大
MTSI
是对方的2.0倍
$139.1M
营收增速更快
MTSI
高出3.0%
21.5%
净利率更高
VCYT
高出2.7%
18.0%
两年增速更快
MTSI
近两年复合增速
10.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $271.6M | $139.1M |
| 净利润 | $48.8M | $28.7M |
| 毛利率 | 55.9% | 72.7% |
| 营业利润率 | 15.9% | 16.3% |
| 净利率 | 18.0% | 20.6% |
| 营收同比 | 24.5% | 21.5% |
| 净利润同比 | 129.1% | — |
| 每股收益（稀释后） | $0.64 | $0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MTSIVCYT
| Q1 26 | $271.6M | $139.1M | ||
| Q4 25 | $261.2M | $140.6M | ||
| Q3 25 | $252.1M | $131.9M | ||
| Q2 25 | $235.9M | $130.2M | ||
| Q1 25 | $218.1M | $114.5M | ||
| Q4 24 | — | $118.6M | ||
| Q3 24 | $200.7M | $115.9M | ||
| Q2 24 | $190.5M | $114.4M |
净利润MTSIVCYT
| Q1 26 | $48.8M | $28.7M | ||
| Q4 25 | $45.1M | $41.1M | ||
| Q3 25 | $36.5M | $19.1M | ||
| Q2 25 | $31.7M | $-980.0K | ||
| Q1 25 | $-167.5M | $7.0M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $29.4M | $15.2M | ||
| Q2 24 | $19.9M | $5.7M |
毛利率MTSIVCYT
| Q1 26 | 55.9% | 72.7% | ||
| Q4 25 | 54.5% | 72.5% | ||
| Q3 25 | 55.3% | 69.2% | ||
| Q2 25 | 55.2% | 69.0% | ||
| Q1 25 | 53.7% | 69.5% | ||
| Q4 24 | — | 66.4% | ||
| Q3 24 | 54.7% | 68.2% | ||
| Q2 24 | 53.2% | 68.1% |
营业利润率MTSIVCYT
| Q1 26 | 15.9% | 16.3% | ||
| Q4 25 | 15.2% | 26.4% | ||
| Q3 25 | 14.9% | 17.4% | ||
| Q2 25 | 14.8% | -4.0% | ||
| Q1 25 | 8.0% | 2.5% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 13.7% | 10.4% | ||
| Q2 24 | 10.4% | 4.0% |
净利率MTSIVCYT
| Q1 26 | 18.0% | 20.6% | ||
| Q4 25 | 17.3% | 29.3% | ||
| Q3 25 | 14.5% | 14.5% | ||
| Q2 25 | 13.4% | -0.8% | ||
| Q1 25 | -76.8% | 6.2% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | 14.7% | 13.1% | ||
| Q2 24 | 10.5% | 5.0% |
每股收益（稀释后）MTSIVCYT
| Q1 26 | $0.64 | $0.35 | ||
| Q4 25 | $0.67 | $0.50 | ||
| Q3 25 | $0.48 | $0.24 | ||
| Q2 25 | $0.42 | $-0.01 | ||
| Q1 25 | $-2.30 | $0.09 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $0.40 | $0.19 | ||
| Q2 24 | $0.27 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $768.5M | $439.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $1.3B |
| 总资产 | $2.1B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MTSIVCYT
| Q1 26 | $768.5M | $439.1M | ||
| Q4 25 | $786.0M | $362.6M | ||
| Q3 25 | $735.2M | $315.6M | ||
| Q2 25 | $681.5M | $219.5M | ||
| Q1 25 | $656.5M | $186.1M | ||
| Q4 24 | — | $239.1M | ||
| Q3 24 | $581.9M | $274.1M | ||
| Q2 24 | $521.5M | $235.9M |
股东权益MTSIVCYT
| Q1 26 | $1.4B | $1.3B | ||
| Q4 25 | $1.3B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.1B |
总资产MTSIVCYT
| Q1 26 | $2.1B | $1.4B | ||
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $1.8B | $1.3B | ||
| Q2 24 | $1.7B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.9M | $35.2M |
| 自由现金流经营现金流 - 资本支出 | $30.0M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 4.8% | — |
| 现金转化率经营现金流/净利润 | 0.88× | 1.23× |
| 过去12个月自由现金流最近4个季度 | $161.5M | — |
8季度趋势，按日历期对齐
经营现金流MTSIVCYT
| Q1 26 | $42.9M | $35.2M | ||
| Q4 25 | $69.6M | $52.6M | ||
| Q3 25 | $60.4M | $44.8M | ||
| Q2 25 | $38.7M | $33.6M | ||
| Q1 25 | $66.7M | $5.4M | ||
| Q4 24 | — | $24.5M | ||
| Q3 24 | $62.3M | $30.0M | ||
| Q2 24 | $49.0M | $29.6M |
自由现金流MTSIVCYT
| Q1 26 | $30.0M | — | ||
| Q4 25 | $49.4M | $48.8M | ||
| Q3 25 | $51.6M | $42.0M | ||
| Q2 25 | $30.5M | $32.3M | ||
| Q1 25 | $61.3M | $3.5M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | $57.1M | $27.7M | ||
| Q2 24 | $41.5M | $26.8M |
自由现金流率MTSIVCYT
| Q1 26 | 11.0% | — | ||
| Q4 25 | 18.9% | 34.7% | ||
| Q3 25 | 20.5% | 31.8% | ||
| Q2 25 | 12.9% | 24.8% | ||
| Q1 25 | 28.1% | 3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | 28.5% | 23.9% | ||
| Q2 24 | 21.8% | 23.4% |
资本支出强度MTSIVCYT
| Q1 26 | 4.8% | — | ||
| Q4 25 | 7.7% | 2.7% | ||
| Q3 25 | 3.5% | 2.1% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.4% | 1.6% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | 2.6% | 1.9% | ||
| Q2 24 | 3.9% | 2.4% |
现金转化率MTSIVCYT
| Q1 26 | 0.88× | 1.23× | ||
| Q4 25 | 1.54× | 1.28× | ||
| Q3 25 | 1.65× | 2.34× | ||
| Q2 25 | 1.22× | — | ||
| Q1 25 | — | 0.76× | ||
| Q4 24 | — | 4.80× | ||
| Q3 24 | 2.12× | 1.98× | ||
| Q2 24 | 2.46× | 5.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTSI
| Industrial Defense | $117.7M | 43% |
| Data Center | $85.8M | 32% |
| Telecom | $68.1M | 25% |
VCYT
| Testing revenue | $135.1M | 97% |
| Product revenue | $3.7M | 3% |
| Biopharmaceutical and other revenue | $301.0K | 0% |
